Disseminated intravascular coagulation epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 11: Line 11:


===Prevalence===
===Prevalence===
*The prevalence of DIC depends on the clinical settings, higher versus low acquity settings.
*The prevalence of [[DIC]] depends on the clinical settings, higher versus low acquity settings.
*In [year], the incidence/prevalence of [disease name] was estimated to be 18.6 per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be 18.6 per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Revision as of 20:05, 23 August 2018

Disseminated intravascular coagulation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Disseminated intravascular coagulation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Disseminated intravascular coagulation epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Disseminated intravascular coagulation epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Disseminated intravascular coagulation epidemiology and demographics

CDC on Disseminated intravascular coagulation epidemiology and demographics

Disseminated intravascular coagulation epidemiology and demographics in the news

Blogs on Disseminated intravascular coagulation epidemiology and demographics

Directions to Hospitals Treating Disseminated intravascular coagulation

Risk calculators and risk factors for Disseminated intravascular coagulation epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]

Overview

Epidemiology and Demographics

Incidence

  • The incidence of DIC is different in different diseases as it is almost always related to a life threatening condition.
  • In 2010, the incidence of DIC was estimated to be 26.2 cases per 100,000 individuals worldwide.[1]

Prevalence

  • The prevalence of DIC depends on the clinical settings, higher versus low acquity settings.
  • In [year], the incidence/prevalence of [disease name] was estimated to be 18.6 per 100,000 individuals worldwide.
  • The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • Patients of all age groups may develop [disease name].
  • The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
  • [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
  • [Chronic disease name] is usually first diagnosed among [age group].
  • [Acute disease name] commonly affects [age group].

Race

  • There is no racial predilection to [disease name].
  • [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developing Countries

References

  1. Singh B, Hanson AC, Alhurani R, Wang S, Herasevich V, Cartin-Ceba R, Kor DJ, Gangat N, Li G (May 2013). "Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004-2010): a population-based study". Chest. 143 (5): 1235–1242. doi:10.1378/chest.12-2112. PMID 23139140.


Template:WS Template:WH